Aktieanalys

Circio ASA: Licensing Deal with TG01 in China Likely - Redeye

{newsItem.title}

Redeye Publicerad: 13 Dec 2023 12:15

Redeye comments on Circio’s partner IOVaxis Therapeutics submission of an application to start a clinical trial with TG01 in China.

Länk till analysen i sin helhet: https://www.redeye.se/research/966694/circio-asa-licensing-deal-with-tg01-in-china-likely?utm_source=finwire&utm_medium=RSS

Nyheter om Circio

Läses av andra just nu

Om aktien Circio

Senaste nytt